Cases of anisocoria have been reported from exposure of the eyes to aerosol bronchodilators.
暴露于使用气溶胶给支气管扩张剂时双侧瞳孔大小不等的病例已经有报道。
As bronchodilators, new type selective anticholinergics play an important role in the treatment of COPD.
新型选择性抗胆碱能药物作为支气管扩张剂在COPD治疗中发挥了重要的作用。
Most patients are managed with the use of inhaled medications called bronchodilators, oxygen and pulmonary rehabilitation.
大多数患者都是靠使用名为支气管扩张剂的吸入性药物、用氧和肺康复疗法来维持的。
Interventions should focus on oxygen therapy, bronchodilators, improving respiratory compliance, cytokines and anti-infective agents respectively.
如吸氧、应用气道扩张药物、改善气道顺应性以及免疫治疗和抗感染治疗等。
Furthermore, bronchial responsiveness significantly improved among both groups, and asthma symptoms and use of rescue bronchodilators significantly decreased.
而且，两组之间的支气管反应性明显得到改善，哮喘症状和支气管扩张剂的抢救使用频率明显减少了。
After inhalation the patient should be kept from further contact with toluene di-isocyanate and, if symptomatic, be given oxygen, bronchodilators, and corticosteroids.
吸入病人应避免进一步接触甲苯二异氰酸酯，如果出现症状，给氧、支气管扩张剂和皮质类固醇。
Since the advances of clinical studies, some new anti-inflammatory drugs and bronchodilators with less adverse reaction, better effect and compliance are in development stage.
国外研究显示，新的药物包括新的支气管扩张剂和抗炎新药，将更好地治疗哮喘，减少不良反应，增加患者依从性。
Treatments of asthma were antibiotic, glucocorticoids and bronchodilators, oral administration or venous transfusion, only 13 21% of patients was given glucocorticoids inhalation.
治疗以口服或静脉滴注抗生素、激素及支气管扩张剂为主，应用吸入疗法仅占13 2 1%。
The present anti-inflammatory drugs and bronchodilators are effective in most cases of bronchial asthma. But there are still some un-controlled bronchial asthma cases and adverse reactions.
虽然目前的抗炎药物和支气管扩张剂等药物对多数支气管哮喘有效，但仍存在不能控制的支气管哮喘病例和一定的不良反应。
The present anti-inflammatory drugs and bronchodilators are effective in most cases of bronchial asthma. But there are still some un-controlled bronchial asthma cases and adverse reactions.
虽然目前的抗炎药物和支气管扩张剂等药物对多数支气管哮喘有效，但仍存在不能控制的支气管哮喘病例和一定的不良反应。
应用推荐